Evidence map›Paper›PMID 29690873›Full record

ReviewMalaria journal2018

Insecticide-treated nets mass distribution campaign: benefits and lessons in Zambia.

Freddie Masaninga, Nawa Mukumbuta, Ketty Ndhlovu, Busiku Hamainza, Pauline Wamulume, Emmanuel Chanda, John Banda, Mercy Mwanza-Ingwe, John M Miller, Birkinesh Ameneshewa and 2 more

Abstract readReview
In one paragraph

Review in Malaria journal, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Observational
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Pediatric Cerebral Malaria.Current tropical medicine reports · 2021
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Freddie MasaningaWorld Health Organization, Lusaka, Zambia. masaningaf@who.int.ORCID http://orcid.org/0000-0002-4040-1736
Nawa MukumbutaSchool of Medicine, Department of Public Health, University of Zambia, Lusaka, Zambia.
Ketty NdhlovuMinistry of Health, National Malaria Elimination Centre, Lusaka, Zambia.
Busiku HamainzaMinistry of Health, National Malaria Elimination Centre, Lusaka, Zambia.
Pauline WamulumeMinistry of Health, National Malaria Elimination Centre, Lusaka, Zambia.
Emmanuel ChandaWorld Health Organization, Africa Regional Office, Lusaka, Zambia.
John BandaMinistry of Health, National Malaria Elimination Centre, Lusaka, Zambia.
Mercy Mwanza-IngweMinistry of Health, National Malaria Elimination Centre, Lusaka, Zambia.
John M MillerPATH Malaria Control and Elimination and Partnership in Africa, Lusaka, Zambia.
Birkinesh AmeneshewaWorld Health Organization, Africa Regional Office, Brazzaville, Congo.
Abraham MnzavaAfrican Leaders Alliance (ALMA), P. O Box 1973, Arusha, Tanzania.
Elizabeth Kawesha-ChizemaMinistry of Health, National Malaria Elimination Centre, Lusaka, Zambia.

Funding

World Health Organization 001
6 · The paper itself

Abstract

backgroundZambia was an early adopter of insecticide-treated nets strategy in 2001, and policy for mass distribution with long-lasting insecticidal nets (LLINs) in 2005. Since then, the country has implemented mass distribution supplemented with routine delivery through antenatal care and under five clinics in health facilities. The national targets of universal (100%) coverage and 80% utilization of LLINs have not been attained. Free mass LLIN distribution campaign in Zambia offers important lessons to inform future campaigns in the African region.

methodsThis study reviewed LLIN free mass distribution campaign information derived from Zambia's national and World Health Organization Global Malaria Programme annual reports and strategic plans published between 2001 and 2016.

resultsIn 2014, a nationwide mass distribution campaign in Zambia delivered all the 6.0 million LLINs in 6 out of 10 provinces in 4 months between June and September before the onset of the rainy season. Compared with 235,800 LLINs and 2.9 million LLINs distributed on a rolling basis in 2008 and 2013, respectively, the 2014 mass campaign, which distributed 6 million LLINs represented the largest one-time-nationwide LLIN distribution in Zambia. The province (Luapula) with highest malaria transmission, mostly with rural settings recorded 98-100% sleeping spaces in homes covered with LLINs. The percentage of households owning at least 1 LLIN increased from 50.9% in 2006 to 77.7% in 2015. The 2014 mass campaign involved a coordinated response with substantial investments into macro (central) and micro (district) level planning, capacity building, tracking and logistics management supported by a new non-health sector partnership landscape. Coordination of LLIN distribution and logistics benefited from the mobile phone technology to transmit "real time" data on commodity tracking that facilitated timely delivery to districts.

conclusionFree mass distribution of LLINs policy was adopted in 2005 in Zambia. Consistently implemented, has not only contributed to increased coverage of LLINs, but has also produced the added value and lessons of strengthening joint planning, strategic coordination, partnerships with non-health sector institutions and community engagement with traditional leaders at community. Furthermore, the mass distribution, through improving coverage has indirect added (spin-off) value or impact on other arthropod-borne diseases, in addition to malaria.

Indexed as

Family CharacteristicsHumansInsecticide-Treated BednetsMosquito ControlOwnershipZambiaImpactMalariaMass distribution of LLINsVector controlZambia

Identifiers

PMID29690873
PMCPMC5916719

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.